Combined first trimester screen or noninvasive prenatal testing or both

Singapore Medical Journal

Volumn 56, Issue 1, 2015, Pages 1-3

  Teck Tan, Tony Yew ^a  

^a RAFFLES HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FREE BETA-HUMAN CHORIONIC GONADOTROPHIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG; CHORIONIC GONADOTROPIN BETA SUBUNIT; PAPPA1 PROTEIN, HUMAN;

AMNIOCENTESIS; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; DEVELOPMENTAL SCREENING; DOWN SYNDROME; ECHOGRAPHY; EDITORIAL; EDWARDS SYNDROME; FEMALE GENITAL TRACT PARAMETERS; FIRST TRIMESTER SCREENING; HEALTH CARE COST; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONINVASIVE PRENATAL TESTING; NUCHAL TRANSLUCENCY MEASUREMENT; PERINATAL DEATH; PREECLAMPSIA; PREMATURE LABOR; PRENATAL SCREENING; TRISOMY 13; TRISOMY 18; TRISOMY 21; UTERINE ARTERY PULSATILITY INDEX; BLOOD; COST BENEFIT ANALYSIS; ECONOMICS; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; MATERNAL SERUM SCREENING TEST; METABOLISM; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; PROCEDURES; STANDARDS;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COST-BENEFIT ANALYSIS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HEALTH CARE COSTS; HUMANS; MATERNAL SERUM SCREENING TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL CARE; PRENATAL DIAGNOSIS;

EID: 84921808733     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2015001     Document Type: Editorial

References (16)

1. College of Obstetricians and Gynaecologists, Singapore. Recommended 'Best Practice' Guidelines on Antenatal Screening for trisomy 21 (Down syndrome) and other Fetal Aneuploidies. January 2008.
2. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011; 31:7-15.
3. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342:c7401.
4. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011; 204:205.e1-11.
5. Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012; 32:3-9.
6. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13:913-20.
7. Bianchi DW, Platt LD, Goldberg JD, et al; MatErnal Blood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119:890-901.
8. The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine. Committee Opinion on Noninvasive Prenatal Testing for Fetal Aneuploidy. Number 545, December 2012.
9. Bianchi DW, Parker RL, Wentworth J, et al; Care Study Group. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370:799-808.
10. Lau TK, Cheung SW, Lo PS, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol 2014; 43:254-64.
11. Liao C, Yin AH, Peng CF, et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. Proc Natl Acad Sci USA 2014; 111:7415-20.
12. Bevilacqua E, Gil MM, Nicolaides KH, et al. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies. Ultrasound Obstet Gynecol 2014 Oct 9. doi: 10.1002/ uog.14690. [Epub ahead of print].
13. Li WS, Barrett AN, Gole L, et al. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort. Singapore Med J 2015: 56:47-52.
14. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013; 41:491-9.
15. Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int 2013; 30:260-79.
16. Syngelaki A, Pergament E, Homfray T, Akolekar R, Nicolaides KH. Replacing the combined test by cell-free DNA testing in screening for trisomies 21, 18 and 13. Fetal Diagn Ther 2014; 35:174-84.